PBH - Prestige Consumer Healthcare to Present at Barclays Global Consumer Staples Investor Conference

TARRYTOWN, N.Y., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) will present at the 2022 Barclays Global Consumer Staples Conference on Thursday, September 8, 2022 at 12:45 p.m. ET. All interested parties may access a live webcast of this event at www.prestigeconsumerhealthcare.com under the "Investors” section and the "Events and Presentations" tab, or by using the following link:

https://ir.prestigebrands.com/events-presentations/events

For those unable to participate during the live webcast, a replay will be available at www.prestigeconsumerhealthcare.com .

About Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare is a leading consumer healthcare products company with sales throughout the U.S. and Canada, Australia, and in certain other international markets. The Company’s diverse portfolio of brands include Monistat ^® and Summer’s Eve ^® women's health products, BC ^® and Goody's ^® pain relievers, Clear Eyes ^® and TheraTears ^® eye care products, DenTek ^® specialty oral care products, Dramamine ^® motion sickness treatments, Fleet® enemas and glycerin suppositories, Chloraseptic ^® and Luden's ^® sore throat treatments and drops, Compound W ^® wart treatments, Little Remedies® pediatric over-the-counter products, Boudreaux’s Butt Paste ^® diaper rash ointments, Nix ^® lice treatment, Debrox ^® earwax remover, Gaviscon ^® antacid in Canada, and Hydralyte ^® rehydration products and the Fess ^® line of nasal and sinus care products in Australia. Visit the Company's website at www.prestigeconsumerhealthcare.com.

Investor Relations ContactPhil Terpolilli, CFA, 914-524-6819irinquiries@prestigebrands.com